Embryo Technology and Stem Cell Research Center

Stem, Thailand

Embryo Technology and Stem Cell Research Center

Stem, Thailand
SEARCH FILTERS
Time filter
Source Type

Sripunya N.,Embryo Technology and Stem Cell Research Center | Sripunya N.,Suranaree University of Technology | Liang Y.,Embryo Technology and Stem Cell Research Center | Liang Y.,Suranaree University of Technology | And 12 more authors.
Cryobiology | Year: 2014

The present study was undertaken to compare the efficacies of Cryotop (CT), solid surface vitrification (SSV) methods and cytochalasin B (CB) treatment for the cryopreservation of immature bovine oocytes, in terms of survival, nuclear maturation, and in vitro development. Solution exposed oocytes were in vitro maturated and fertilized. No difference was found in the rates of survival, nuclear maturation and blastocyst among solution exposed groups and fresh control group, except blastocysts rates in oocytes exposed to CB, cryoprotectant (CPA) and fluorescein diacetate (FDA) group (CB-CPA-FDA) (23%) significantly lower than that of control group (32%). CB pretreated ((+)CB) or non-pretreated ((-)CB) COCs were vitrified either by SSV or CT. Among four vitrified groups the nuclear maturation rates (CT(-)CB: 58%, CT(+)CB: 57%, SSV(-)CB: 60%, SSV(+)CB: 63%), cleavage (CT(-)CB: 36%, CT(+)CB: 24%, SSV(-)CB: 34%, SSV(+)CB: 26%) and blastocysts rates (CT(-)CB: 6%, CT(+)CB: 7%, SSV(-)CB: 4%, SSV(+)CB: 6%) did not differ, but the rates of the four vitrified groups were significantly lower than those of non-vitrified group (81%, 71% and 26%, respectively). We thus conclude that CT and SSV perform equally in vitrification of bovine immature oocytes, and CB did not increase the viability, nuclear maturation, or in vitro development of vitrified oocytes. © 2014 Elsevier Inc.

Loading Embryo Technology and Stem Cell Research Center collaborators
Loading Embryo Technology and Stem Cell Research Center collaborators